LAST CHANCE TO SAVE! New Trends for Life Sciences at PACK EXPO Southeast
Discover all the latest packaging solutions for life sciences products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025
REGISTER ASAP FOR $30!

Adapt Pharma’s Nasal Spray Uses Unit-Dose Delivery System

Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.
Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

Last November, the U.S. FDA approved Radnor, PA-based Adapt Pharma’s NARCAN® (naloxone hydrochloride) nasal spray for the emergency treatment of known or suspected opioid overdose.

Aptar Pharma recently announced that it provided the delivery system and regulatory support for Narcan, which it referred to as “the first U.S. FDA-approved nasally administered, needle-free, ready-to use medication that can stop or reverse the effects of an opioid overdose.”

The liquid spray drug delivery technology platform provides dose accuracy and ease of administration. The single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
REGISTER ASAP FOR $30!
LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast